The impact of biotechnology on pharmaceutical manufacturing: Revolutionizing production processes

https://doi.org/10.53730/ijhs.v3nS1.15019

Authors

  • Nawal Hlal Almutairi KSA, National Guard Health Affairs
  • Nawal Ganai M Bahari KSA, National Guard Health Affairs
  • Alhanouf Zaid Almutairi KSA, National Guard Health Affairs
  • Samar Saad Alotaibi KSA, National Guard Health Affairs
  • Faisal Nasser Alharbi KSA, National Guard Health Affairs
  • Manal Nasser Almasad KSA, National Guard Health Affairs

Keywords:

Bioengineering, Pharmaceutical Bioproducts, System Biology, Synthetic Biology, Nano Bioengineering

Abstract

Background _ Bioengineering tools have revolutionized the production of pharmaceutical bioproducts by streamlining processes and reducing the time required for development. These tools are applicable across various biological platforms, including plants, animals, and microorganisms, offering substantial advantages in the pharmaceutical industry. Aim of Work – This review aims to highlight the benefits and advancements in bioengineering tools for pharmaceutical production and to propose strategies for enhancing the economic feasibility of these processes at both biological and process bioengineering levels. Methods – A comprehensive analysis of current literature was conducted to evaluate the advancements in bioengineering tools, including system biology, synthetic biology, transcriptomics, proteomics, metabolomics, and nano bioengineering. The review also examined the challenges faced in pharmaceutical production and the tools available to address these challenges. Results – The findings indicate that the development of pharmaceutical bioproducts is significantly influenced by advancements in system biology and synthetic biology. Key bioengineering tools, such as transcriptome, proteome, metabolome analyses, and nano bioengineering, play a crucial role in addressing the challenges associated with pharmaceutical production. The review also identifies potential breakthroughs that can enhance the production process and improve economic feasibility. 

Downloads

Download data is not yet available.

References

Khatodia S, Khurana SMP. Genetic engineering for plant transgenesis. In: omics Technologies and Bio-Engineering. Elsevier; 2018. P. 71–86.

Jozala AF, Geraldes DC, Tundisi LL, et al. Biopharmaceuticals from microorganisms: from production to purification. Braz J Microbiol. 2016;47:51–63.

Sangwan NS, Jadaun JS, Tripathi S, et al. Plant Metabolic Engineering. In: Omics Technologies and Bio-Engineering. Elsevier; 2018. P. 143–175

Kalia A. Chapter 12 – Nanotechnology in Bioengineering: transmogrifying Plant Biotechnology. In: Barh D, Azevedo V, editors. Omics Technologies and Bio-Engineering. Academic Press; 2018. P. 211–229.

Wang G, Huang M, Nielsen J. Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production. Curr Opin Biotech. 2017 Dec;48:77–84.

Patil RH, Patil MP, Maheshwari VL. Bioactive secondary metabolites from endophytic fungi. In: Studies in natural products chemistry. Elsevier; 2016. P. 189–205.

Xu N, Zhu J, Q Z, et al. Identification and characterization of novel promoters for recombinant protein production in yeast Pichia pastoris. Yeast. Wiley. 2018 8;35(5):379–385.

Qiao W, Ling F, Yu L, et al. Enhancing taxol production in a novel endophytic fungus, Aspergillus aculeatinus Tax-6, isolated from Taxus chinensis var. mairei. Fungal Biol. 2017;121(12):1037–1044.

Kumaran RS, Kim HJ, Hur B-K. Taxol promising fungal endophyte, Pestalotiopsis species isolated from Taxus uspidate. J Biosci Bioeng. 2010;110(5):541–546.

Yang N, Pan X, Chen G, et al. Fermentation engineering for enhanced paclitaxel production by taxus media endophytic fungus MF-5 (Alternaria sp.). J Biobased Mater Bio. 2018;12(6):545–550.

Sudhakar N, Shanmugam H, Kumaran S, et al. Omics approaches in fungal biotechnology. In Omics Technologies and Bio-Engineering. Elsevier; 2018. P. 53–70.

Tzani I, Monger C, Kelly P, et al. Understanding biopharmaceutical production at single nucleotide resolution using ribosome footprint profiling. Curr Opin Biotech. 2018;53:182–190.

Gomes E, de Souza AR, Orjuela GL, Da Silva R, de Oliveira TB, Rodrigues A. Applications and benefits of thermophilic microorganisms and their enzymes for industrial biotechnology. Gene expression systems in fungi: advancements and applications. 2016:459-92.

Brown DP, Rogers DT, Gunjan SK, et al. Target-directed discovery and production of pharmaceuticals in transgenic mutant plant cells. J Biotechnol. 2016;238:9–14.

Breitling R, Takano E. Synthetic biology advances for pharmaceutical production. Curr Opin Biotech. 2015;35:46–51.

Li H, Shen CR, Huang CH, et al. CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production. Metab Eng. 2016;38:293–302.

Ahn SR, An JH, Song HS, Park JW, Lee SH, Kim JH, Jang J, Park TH. Duplex bioelectronic tongue for sensing umami and sweet tastes based on human taste receptor nanovesicles. ACS nano. 2016 Aug 23;10(8):7287-96.

Amitai G, Sorek R. PanDaTox. Bioengineered. 2012;3(4):218–221.

Nakamae K, Nishimura Y, Takenaga M, et al. Establishment of expanded and streamlined pipeline of PITCh knock-in – a web-based design tool for MMEJ-mediated gene knock-in, PITCh designer, and the variations of PITCh, PITCh-TG and PITCh-KIKO. Bioengineered. 2017;8(3):302–308.

Ventura M, Turroni F, van Sinderen D. Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut. Bioengineered. 2012;3(2):73–79.

Dziadek B, Brzostek A. Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis. Bioengineered. 2012;3(6):358–364.

Kick L, Kirchner M, Schneider S. CRISPR-Cas9: from a bacterial immune system to genome-edited human cells in clinical trials. Bioengineered. 2017;8(3):280–286.

Khatodia S, Bhatotia K, Tuteja N. Development of CRISPR/Cas9 mediated virus resistance in agriculturally important crops. Bioengineered. 2017;8(3):274–279.

Nakade S, Yamamoto T, Sakuma T. Cas9, Cpf1 and C2c1/2/3—What’s next? Bioengineered. 2017;8(3):265–273.

Li Y, Li S, Li Y, et al. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene. Bioengineered. 2018;10(1):98–107.

Perez RF, Nyman RKM, Johnson AAT, et al. CRISPR-Cas systems: ushering in the new genome editing era. Bioengineered. 2018;9(1):214–221.

Al-Omari S, Mubarak AA, Al-Noaimi M, et al. Multielemental analysis of pharmaceuticals derived from plant seeds by energy dispersive X-ray fluorescence spectrometry. Instrum Sci Technol. 2015;44(1):98–113.

Schofield DA, Bull CT, Rubio I, et al. “Light-tagged” bacteriophage as a diagnostic tool for the detection of phytopathogens. Bioengineered. 2013;4(1):50–54.

Sarsaiya S, Jia Q, Fan X, et al. First report of leaf black circular spots on Dendrobium nobile caused by Trichoderma longibrachiatum in Guizhou Province, China. Plant Dis. 2019. Doi:https://doi.org/10.1094/pdis-03-19-0672-pdn.

Narnoliya LK, Kaushal G, Singh SP, et al. De novo transcriptome analysis of rose-scented geranium provides insights into the metabolic specificity of terpene and tartaric acid biosynthesis. BMC Genomics. 2017;18(1). DOI:https://doi.org/10.1186/s12864-016-3437-0

Mashima J, Kodama Y, Fujisawa T, et al. DNA Data Bank of Japan. Nucleic Acids Res. 2017;45:D25–D31.

Baker W, van Den Broek A, Camon E, et al. The EMBL nucleotide sequence database. Nucleic Acids Res. 2000;28(1):19–23.

Buchmann JP, Holmes EC. Entrezpy: A Python library to dynamically interact with the NCBI Entrez databases. Bioinformatics. 2019;11:btz385.

Dwane S, Kiely PA. Tools used to study how protein complexes are assembled in signaling cascades. Bioengineered Bugs. 2011;2(5):247–259.

Mukherjee S, Stamatis D, Bertsch J, et al. Genomes online database (GOLD) v.6: data updates and feature enhancements. Nucleic Acids Res. 2017;45:D446–D456.

Bekker V, Dodd A, Brady D, et al. Tools for metabolic engineering in Streptomyces. Bioengineered. 2014;5(5):293–299.

Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110.

Parkinson H, Kapushesky M, Shojatalab M, et al. ArrayExpress—a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 2007;35:D747–D750.

Gasteiger E, Gattiker A, Hoogland C, et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31(13):3784–3788.

Mewes HW, Frishman D, Güldener U, et al. MIPS: a database for genomes and protein sequences. Nucleic Acids Res. 2002;30(1):31–34.

von Mering C, Huynen M, Jaeggi D, et al. STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258–261.

Bairoch A. The ENZYME database in 2000. Nucleic Acids Res. 2000;28(1):304–305.

Schomburg I, Chang A, Schomburg D. BRENDA, enzyme data and metabolic information. Nucleic Acids Res. 2002;30(1):47–49.

Karp PD, Billington R, Holland TA, et al. Computational metabolomics operations at BioCyc.org. Metabolites. 2015;5(2):291–310.

Published

15-01-2019

How to Cite

Almutairi, N. H., Bahari, N. G. M., Almutairi, A. Z., Alotaibi, S. S., Alharbi, F. N., & Almasad, M. N. (2019). The impact of biotechnology on pharmaceutical manufacturing: Revolutionizing production processes. International Journal of Health Sciences, 3(S1), 71–85. https://doi.org/10.53730/ijhs.v3nS1.15019

Issue

Section

Peer Review Articles

Most read articles by the same author(s)